LicenseCompare

Monetary Authority of Singapore

Singapore research licensing requirements

Securities research, model portfolios, newsletters, platform commentary, ratings, and recommendation-like analysis. This page maps the issue to Singapore application evidence, individual roles, corporate controls, public registers, and official sources.

Who this page is for

  • - Research providers
  • - Newsletter publishers
  • - Analyst platforms
  • - Advisory firms adding research
  • - Fund managers serving accredited or institutional investors
  • - Broker-dealers and product distributors

Likely route questions

  • - Research and financial advice analysis depending on distribution and product coverage

Activity trigger map

  • - Is the research general or tailored to a user, portfolio, product, or trade?
  • - Are analysts paid by issuers, distributors, transaction activity, or subscribers?
  • - How are conflicts, disclaimers, and distribution controls handled?
  • - Which entity will provide investment research?
  • - How will professional, accredited, institutional, or wholesale client status be evidenced and monitored?
  • - Which domestic permissions, representative approvals, and ongoing obligations apply before launch?

Individual requirements

  • - Appointed representatives for regulated activities conducted on behalf of CMS licensees or exempt financial institutions
  • - Fit and proper assessment for directors, representatives, substantial shareholders, and key persons
  • - Activity-specific entry and examination requirements where applicable
  • - Clear senior ownership for compliance, AML/CFT, risk, and operations

Corporate requirements

  • - Singapore entity with clear proposed activities and product scope
  • - Business plan, financial resources, compliance arrangements, AML/CFT program, and risk management framework
  • - Representative framework and supervision model
  • - Client classification and marketing controls for retail, accredited, and institutional clients

People and key-person expectations

  • - Appointed representatives for regulated activities conducted on behalf of CMS licensees or exempt financial institutions
  • - Fit and proper assessment for directors, representatives, substantial shareholders, and key persons
  • - Activity-specific entry and examination requirements where applicable
  • - Named owners should be able to explain the activity workflow, client type, controls, and evidence pack.

Documents and evidence checklist

  • - People and competence
  • - Compliance framework
  • - Governance and accountability
  • - Complaints and conduct
  • - Regulatory reporting
  • - Official-source route memo
  • - Public register verification plan
  • - Questions log for qualified advisers

Capital, timeline and bottlenecks

Capital and financial resource expectations depend on activity, client type, custody, and the specific licence or exemption path.

Timeline estimate: Typically 4 to 9+ months depending on route and readiness.

  • - Assuming accredited or institutional clients remove all licensing questions
  • - Weak explanation of investment strategy, risk management, or outsourced functions
  • - Unclear representative arrangements and supervision
  • - Marketing plans that drift into retail or public solicitation without controls

Common mistakes

  • - Relying on disclaimers while the product journey feels like personalised advice.
  • - Not controlling conflicts, issuer payments, or sales follow-up.
  • - Do not rely on an exemption without mapping the exact entity, activity, client, and marketing facts.
  • - Representative status and individual conduct controls are not afterthoughts.

Disclaimer

Information on LicenseCompare is for general educational purposes only and does not constitute legal, regulatory, financial, tax, investment, or professional advice. Licensing requirements depend on facts and change over time. Always consult official regulator materials and qualified professional advisers.